Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brad Jones

Showing results (41-50 of 133) with videos related to

Pageof 14
Sort By:
Research Square|June 10, 2024
Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in CancerErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
International Journal of Nanomedicine|July 31, 2023
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIVJoshua Ghofrani, Allan Bowen, Jie Chen, et al.
JCI Insight|October 5, 2018
Dual TLR2 and TLR7 agonists as HIV latency-reversing agentsAmanda B Macedo, Camille L Novis, Caroline M De Assis, et al.
Molecular Therapy. Methods & Clinical Development|October 2, 2020
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIVAllison B Powell, Yanqin Ren, Maria Korom, et al.
Journal of Virology|January 11, 2019
Establishment of a Novel Humanized Mouse Model To Investigate <i>In Vivo</i> Activation and Depletion of Patient-Derived HIV Latent ReservoirsNina C Flerin, Ariola Bardhi, Jian Hua Zheng, et al.
Journal of Virology|June 26, 2009
Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutationsR Brad Jones, Feng-Yun Yue, Xiao Xiao Jenny Gu, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2020
Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing AgentsEric S Sorensen, Amanda B Macedo, Rachel S Resop, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2018
Phylogenetic approach to recover integration dates of latent HIV sequences within-hostBradley R Jones, Natalie N Kinloch, Joshua Horacsek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral controlFeng Yun Yue, Calvin Lo, Ali Sakhdari, et al.
Journal of Immunological Methods|August 31, 2015
A robust and scalable TCR-based reporter cell assay to measure HIV-1 Nef-mediated T cell immune evasionGursev Anmole, Xiaomei T Kuang, Mako Toyoda, et al.
Pageof 14

Showing results (41-50 of 133) with videos related to

Sort By:
Pageof 14
Research Square|June 10, 2024
Limited Immunogenicity of an HLA-A*03:01-restricted Epitope of Erv-k-env in Non-hiv-1 Settings: Implications for Adoptive Cell Therapy in CancerErin E Grundy, Lauren C Shaw, Loretta Wang, et al.
International Journal of Nanomedicine|July 31, 2023
Nanodepots Encapsulating a Latency Reversing Agent and Broadly Neutralizing Antibody Enhance Natural Killer Cell Cytotoxicity Against an in vitro Model of Latent HIVJoshua Ghofrani, Allan Bowen, Jie Chen, et al.
JCI Insight|October 5, 2018
Dual TLR2 and TLR7 agonists as HIV latency-reversing agentsAmanda B Macedo, Camille L Novis, Caroline M De Assis, et al.
Molecular Therapy. Methods & Clinical Development|October 2, 2020
Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIVAllison B Powell, Yanqin Ren, Maria Korom, et al.
Journal of Virology|January 11, 2019
Establishment of a Novel Humanized Mouse Model To Investigate <i>In Vivo</i> Activation and Depletion of Patient-Derived HIV Latent ReservoirsNina C Flerin, Ariola Bardhi, Jian Hua Zheng, et al.
Journal of Virology|June 26, 2009
Human immunodeficiency virus type 1 escapes from interleukin-2-producing CD4+ T-cell responses without high-frequency fixation of mutationsR Brad Jones, Feng-Yun Yue, Xiao Xiao Jenny Gu, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2020
Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing AgentsEric S Sorensen, Amanda B Macedo, Rachel S Resop, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2018
Phylogenetic approach to recover integration dates of latent HIV sequences within-hostBradley R Jones, Natalie N Kinloch, Joshua Horacsek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2010
HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral controlFeng Yun Yue, Calvin Lo, Ali Sakhdari, et al.
Journal of Immunological Methods|August 31, 2015
A robust and scalable TCR-based reporter cell assay to measure HIV-1 Nef-mediated T cell immune evasionGursev Anmole, Xiaomei T Kuang, Mako Toyoda, et al.
Pageof 14